-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Newborns will be vaccinated against hepatitis B within 24 hours of birth, and the second and third doses will be given 1 month and 6 months later
.
But in the face of hepatitis B virus, many people will worry about whether they will be immune for life after injection of hepatitis B vaccine? During the physical examination, it is found that there is no hepatitis B antibody.
Newborns will be vaccinated against hepatitis B within 24 hours of birth, and the second and third doses will be given 1 month and 6 months later
People at high risk of hepatitis B need to monitor antibodies on a regular basis.
myocardial infarction
To compare acute MI rates between recipients of HepB-CpG vaccine and HepB-alum vaccine, scholars from the United States conducted a prospective cohort non-inferiority study, and the results were published in the journal JAMA
.
The study included 69,625 adults not on dialysis who received at least one dose of the hepatitis B vaccine between Aug.
JAMA
RESULTS: Among 31,183 HepB-CpG vaccine recipients (median age = 49 years; IQR, 38-56 years), 51.
2% (n = 15965) were male and 52.
7% (n = 16423) were Hispanic
.
Of the 38,442 HepB-alum recipients (median age, 49 years; IQR, 39-56 years), 50.
After inverse probability treatment weighting, characteristics were well balanced across vaccine groups
.
Fifty-two type 1 acute MI events were confirmed in the population receiving the HepB-CpG vaccine, a rate of 1.
Fifty-two type 1 acute MI events were confirmed in the population receiving the HepB-CpG vaccine, a rate of 1.
Cumulative incidence of confirmed acute myocardial infarction among hepatitis B vaccine recipients
Cumulative incidence of confirmed acute myocardial infarction among hepatitis B vaccine recipientsIn this cohort study, receiving the HepB-CpG vaccine did not meet the statistical criteria for an increased risk of acute myocardial infarction compared with the HepB-alum vaccine
.
.
In this cohort study, receiving the HepB-CpG vaccine did not meet the statistical criteria for an increased risk of acute myocardial infarction compared with the HepB-alum vaccine .
references:
Association Between 2-Dose vs 3-Dose Hepatitis B Vaccine and Acute Myocardial Infarction.
JAMA.
Association Between 2-Dose vs 3-Dose Hepatitis B Vaccine and Acute Myocardial Infarction.
JAMA.
Published online March 25, 2022.
doi:10.
1001/jama.
2022.
2540 Association Between 2-Dose vs 3-Dose Hepatitis B Vaccine and Acute Myocardial Infarction.
leave a message here
